Vedolizumab

Also known as Entyvio (us)

Save $67,006/mo

2× cheaper

Vedolizumab injection is used to treat: Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever).

United States

$132,871

per month

India

$65,865

per month

You save

$67,006

50% cheaper in India

18.7K US scripts/yr$1.3B potential annual savings$2.5B US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$132,871per month

India price$65,865per month

You save$67,00650% less

Based on 30 units per month. US $4,429.03 vs India $2,195.51 per unit.

How many months / courses?

Total over 1 periodSave $67,006$132,871 → $65,865

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $402,035
Estimated travel cost: − $2,300
Net savings after travel: $399,735

Even after travel, you could come out ahead by about $399,735.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Vedolizumab is filled about 18.7K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$2.5B

If sourced from India

$1.2B

Potential annual savings

$1.3B

−50%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.